BioLASCO Taiwan Co (ROCO:6662) PEG Ratio: N/A (As of Jul. 22, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6662 BioLASCO Taiwan Co Ltd ROCO:6662
77 GF Score
Price NT$29.70
GF Value NT$34.19
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is BioLASCO Taiwan Co PEG Ratio?

PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, BioLASCO Taiwan Co's PE Ratio without NRI is 17.98. BioLASCO Taiwan Co's 5-Year EBITDA growth rate is -4.30%. Therefore, BioLASCO Taiwan Co's PEG Ratio for today is N/A.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


The historical rank and industry rank for BioLASCO Taiwan Co's PEG Ratio or its related term are showing as below:


During the past 12 years, BioLASCO Taiwan Co's highest PEG Ratio was 15.13. The lowest was 1.97. And the median was 2.01.


ROCO:6662's PEG Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 1.97
* Ranked among companies with meaningful PEG Ratio only.

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.


BioLASCO Taiwan Co  (ROCO:6662) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.


BioLASCO Taiwan Co PEG Ratio Related Terms


BioLASCO Taiwan Co PEG Ratio Historical Data

* Premium members only.

The historical data trend for BioLASCO Taiwan Co's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioLASCO Taiwan Co PEG Ratio Chart

BioLASCO Taiwan Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
PEG Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.30 0.00 0.00 0.00 0.00

BioLASCO Taiwan Co Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
PEG Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

ROCO:6662 vs VRTX, REGN, ALNY: PEG Ratio Comparison

For the Biotechnology subindustry, BioLASCO Taiwan Co's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioLASCO Taiwan Co PEG Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BioLASCO Taiwan Co's PEG Ratio distribution charts can be found below:

* The bar in red indicates where BioLASCO Taiwan Co's PEG Ratio falls into.


ROCO:6662
77GF Score
BioLASCO Taiwan Co Ltd ROCO:6662
PEG Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BioLASCO Taiwan Co PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

BioLASCO Taiwan Co's PEG Ratio for today is calculated as

PEG Ratio=PE Ratio without NRI/5-Year EBITDA Growth Rate*
=17.978208232446/-4.30
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.

Is BioLASCO Taiwan Co (ROCO:6662) Overvalued in 2026?

Based on GuruFocus' analysis, BioLASCO Taiwan Co stock appears to be undervalued. The current stock price of NT$29.70 is trading 13.1% below its estimated GF Value™ of NT$34.19. GuruFocus considers BioLASCO Taiwan Co to be Modestly Undervalued.

Key valuation signals for ROCO:6662:

  • PEG Ratio: N/A
  • GF Value™: NT$34.19 vs. price of NT$29.70 (13.1% below fair value)
  • GF Score™: 77/100 with 4 warning signs

No single metric tells the full story. See the ROCO:6662 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


BioLASCO Taiwan Co Business Description

Address 316 Chong-yang Road, 2nd Floor, Nangang District, Taipei, TWN, 115
BioLASCO Taiwan Co Ltd is a biological experimental development company. The company has produced strains of laboratory rats and mice, including outbreed stocks, inbreed strains, and immunedeficient models. It offers reagent kits and equipment which include Allentown, a Biomedical data system, and PLAS LABS.
77GF Score

Get the complete analysis for ROCO:6662

PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$29.70
Price
NT$34.19
GF Value